Video

Testosterone therapy does not appear to worsen outcomes in men with COVID-19

Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.

In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.

More videos:

Setting expectations in patients with prostate cancer receiving HIFU

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications

Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
Urology Times Mitomycin RX Review Square Thumb
© 2025 MJH Life Sciences

All rights reserved.